PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

VOLORIDGE INVESTMENT MANAGEMENT, LLC's Holding History (CIK: 0001556921)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023

Shares 15,588 Value ($000) $431 Avg Close $25.03 Range $17.64 - $30.10

Q1 2023

Shares 465,323 Value ($000) $10,702 Avg Close $16.79 Range $10.62 - $25.69

Q4 2022

Shares 167,369 Value ($000) $1,826 Avg Close $8.44 Range $7.24 - $11.46

Q3 2022

Shares 426,393 Value ($000) $3,594 Avg Close $9.46 Range $7.68 - $11.97

Q2 2022

Shares 596,487 Value ($000) $4,718 Avg Close $12.09 Range $6.91 - $25.76

Q1 2022

Shares 76,601 Value ($000) $1,814 Avg Close $28.17 Range $22.56 - $37.05

Q4 2021

Shares 183,648 Value ($000) $6,281 Avg Close $31.61 Range $17.26 - $38.11

Q3 2021

Shares 550,083 Value ($000) $9,747 Avg Close $42.63 Range $12.80 - $50.54

Q2 2021

Shares 6,504 Value ($000) $292 Avg Close $33.01 Range $24.14 - $45.93

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2023	15,588	$431	$25.03	$17.64 - $30.10
Q1 2023	465,323	$10,702	$16.79	$10.62 - $25.69
Q4 2022	167,369	$1,826	$8.44	$7.24 - $11.46
Q3 2022	426,393	$3,594	$9.46	$7.68 - $11.97
Q2 2022	596,487	$4,718	$12.09	$6.91 - $25.76
Q1 2022	76,601	$1,814	$28.17	$22.56 - $37.05
Q4 2021	183,648	$6,281	$31.61	$17.26 - $38.11
Q3 2021	550,083	$9,747	$42.63	$12.80 - $50.54
Q2 2021	6,504	$292	$33.01	$24.14 - $45.93